2016
DOI: 10.3324/haematol.2015.131128
|View full text |Cite
|
Sign up to set email alerts
|

Circulating cell-free DNA in hematological malignancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
24
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(25 citation statements)
references
References 29 publications
1
24
0
Order By: Relevance
“…Aside from several physiological states such as pregnancy and physical activity, pathological conditions, including inflammation and autoimmune diseases, may present with elevated cfDNA levels. In cancer, cfDNA levels may be increased up to 1000 ng/mL, which draws attention to an association between cfDNA levels and tumor burden (1,4,8,(10)(11)(12)(13). A previously reported association between age and cfDNA was confirmed in our study.…”
Section: Discussionsupporting
confidence: 85%
See 3 more Smart Citations
“…Aside from several physiological states such as pregnancy and physical activity, pathological conditions, including inflammation and autoimmune diseases, may present with elevated cfDNA levels. In cancer, cfDNA levels may be increased up to 1000 ng/mL, which draws attention to an association between cfDNA levels and tumor burden (1,4,8,(10)(11)(12)(13). A previously reported association between age and cfDNA was confirmed in our study.…”
Section: Discussionsupporting
confidence: 85%
“…As serum cfDNA levels are expected to be more variable than plasma levels, higher serum cfDNA levels are suggested to possibly represent an indirect tumor-related process, whereas plasma levels may be a better indicator of in vivo circulating DNA (4)(5)(6)9,15,16). Alongside WBC count, several factors may affect cfDNA analysis, such as individualized variations, diurnal rhythm, inflammatory responses, and physical stimuli (1). Although sample preference would be considered an eventual limitation for the present study, we did not mean to discriminate the impact of WBCs on the entire process, considering the potential role of leukocytes in the leukemia microenvironment.…”
Section: Cfdna: Cell-free Deoxyribonucleic Acidmentioning
confidence: 99%
See 2 more Smart Citations
“…Detecting ctDNA from blood plasma and serum is challenging as it accounts only for a small fraction (less than 1%) of the total amount of cfDNA, and preanalytical processes including blood collection, purification, and storage are not yet fully standardized [19]. For ctDNA analysis, blood plasma is preferred over serum due to less contamination with genomic DNA (gDNA) by blood cell lysis, which occurs during clotting (17).…”
Section: Introductionmentioning
confidence: 99%